Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy.

Abstract

BACKGROUND Neuromyotonia (NMT) has been postulated to be an autoimmune channelopathy, probably by affecting voltage gated potassium channels (VGKC) leading to excitation and abnormal discharges [Sinha et al., Lancet 338 (1991) 75]. OBJECTIVE To report three patients with NMT who had other associated immune-mediated conditions, i.e., myasthenia gravis… (More)

Topics

Cite this paper

@article{Hayat2000NeuromyotoniaAP, title={Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy.}, author={Ghazala R Hayat and Kongkiat Kulkantrakorn and William W. Campbell and Matteo Giuliani}, journal={Journal of the neurological sciences}, year={2000}, volume={181 1-2}, pages={38-43} }